{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:40:04Z","timestamp":1751499604264,"version":"3.41.0"},"reference-count":27,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Primary or idiopathic osteonecrosis of femur head (ONFH) is the second most commonly observed cause among Indian patients suffering from ischemic ONFH. Although a number of genetic polymorphisms have been associated with idiopathic ONFH pathogenesis in Korean and Chinese populations, there are no studies in the Indian population. This is an exploratory study designed to implicate in promoter sequence polymorphisms of a critical fibrinolytic system regulator, plasminogen activator inhibitor-1 (PAI-1) gene, in cases of idiopathic osteonecrosis. Promoter sequence variations can affect expression levels of PAI-1 gene and may disrupt the coagulation\/fibrinolytic equilibrium, which may finally culminate into osteonecrosis. Hence, the aim of the study was to investigate the role of single-nucleotide polymorphisms (SNPs) in the promoter region of PAI-1 gene and osteonecrosis development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Two SNPs of the PAI-1 gene (rs2227631, -844 G\/A; rs1799889, -675 4G\/5G) were genotyped in 25 patients diagnosed with idiopathic ONFH and 25 control subjects, using direct sequencing. Subsequently, association analyses were performed for the genotyped SNPs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Both the rs2227631 and rs1799889 genotype and allele frequencies of PAI-1 gene showed an insignificant association with osteonecrosis risk (P=0.717, 0.149). Haplotype frequencies of rs2227631 and rs1799889 were also calculated in patients having idiopathic ONFH and controls. Although the distribution of haplotype GA-4G 4G was found to be the highest among the cases, it was not significantly different when compared with the controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>Our findings demonstrate that the minor alleles of promoter region sequences of the PAI-1 gene do not contribute to an increase in ONFH predisposition. However, this is a preliminary study and its findings should be considered as suggestive for studies to be done in a larger sample size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_496_19","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T08:55:32Z","timestamp":1654505732000},"page":"849-856","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur"],"prefix":"10.25259","volume":"154","author":[{"given":"Srishty","family":"Raman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Dada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapas Chandra","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Shekhar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-13-20241212","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s007760200108","article-title":"The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head","volume":"7","author":"Sugano","year":"2002","journal-title":"J Orthop Sci"},{"key":"R2-13-20241212","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/ortho.IJOrtho_292_16","article-title":"Epidemiological profile of femoral head osteonecrosis in the North Indian population","volume":"52","author":"Vardhan","year":"2018","journal-title":"Indian J Orthop"},{"key":"R3-13-20241212","first-page":"65","article-title":"Stem cell treatment for avascular necrosis of the femoral head: current perspectives","volume":"7","author":"Houdek","year":"2014","journal-title":"Stem Cells Cloning"},{"key":"R4-13-20241212","first-page":"34","article-title":"Coronary disease of the hip","volume":"11","author":"Chandler","year":"1948","journal-title":"J Int Coll Surg"},{"key":"R5-13-20241212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003086-200408000-00023","article-title":"Factor V leiden and prothrombin gene mutation: Risk factors for osteonecrosis of the femoral head in adults","volume":"425","author":"Bj\u00f6rkman","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"R6-13-20241212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","volume":"386","author":"Glueck","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"R7-13-20241212","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.transproceed.2005.12.062","article-title":"Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients","volume":"38","author":"Celik","year":"2006","journal-title":"Transplant Proc"},{"key":"R8-13-20241212","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007890-200210270-00016","article-title":"Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients","volume":"74","author":"Ferrari","year":"2002","journal-title":"Transplantation"},{"key":"R9-13-20241212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00003086-199909000-00017","article-title":"The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis","volume":"366","author":"Glueck","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"R10-13-20241212","first-page":"525","article-title":"Relationship between Post-SARS osteonecrosis and PAI-1 4 G\/5 G gene polymorphisms","volume":"24","author":"Sun","year":"2014","journal-title":"Orthop J China"},{"key":"R11-13-20241212","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2474-12-160","article-title":"Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head","volume":"12","author":"Kim","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"R12-13-20241212","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.TP.0000101433.99651.96","article-title":"Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects","volume":"77","author":"Asano","year":"2004","journal-title":"Transplantation"},{"key":"R13-13-20241212","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/j.1460-2075.1986.tb04532.x","article-title":"Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family","volume":"5","author":"Pannekoek","year":"1986","journal-title":"EMBO J"},{"key":"R14-13-20241212","doi-asserted-by":"crossref","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: Structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R15-13-20241212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.trsl.2006.05.001","article-title":"Comparative analysis of serum proteomes: Discovery of proteins associated with osteonecrosis of the femoral head","volume":"148","author":"Tan","year":"2006","journal-title":"Transl Res"},{"key":"R16-13-20241212","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","article-title":"PAI-1 and atherothrombosis","volume":"3","author":"Vaughan","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R17-13-20241212","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1055-9965.EPI-06-0351","article-title":"Prognostic value of PAI 1 in invasive breast cancer: Evidence that tumor-specific factors are more important than genetic variation in regulating PAI 1 expression","volume":"15","author":"Sternlicht","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-13-20241212","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00296-007-0453-z","article-title":"The -844 G\/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis","volume":"28","author":"Torres-Carrillo","year":"2008","journal-title":"Rheumatol Int"},{"key":"R19-13-20241212","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1160\/TH10-04-0243","article-title":"Allele-specific transcription of the PAI-1 gene in human astrocytes","volume":"104","author":"Hultman","year":"2010","journal-title":"Thromb Haemost"},{"key":"R20-13-20241212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","article-title":"Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity","volume":"11","author":"Dawson","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"R21-13-20241212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2012.03.090","article-title":"Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer\u2019s disease","volume":"516","author":"Fang","year":"2012","journal-title":"Neurosci Lett"},{"key":"R22-13-20241212","first-page":"195","article-title":"Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor","volume":"71","author":"Glueck","year":"1994","journal-title":"Thromb Haemost"},{"key":"R23-13-20241212","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2474-14-264","article-title":"Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland","volume":"14","author":"Gagala","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"R24-13-20241212","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"R25-13-20241212","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00296-011-2279-y","article-title":"PAI-1 mRNA expression and plasma level in rheumatoid arthritis: Relationship with 4G\/5G PAI-1 polymorphism","volume":"32","author":"Mu\u00f1oz-Valle","year":"2012","journal-title":"Rheumatol Int"},{"key":"R26-13-20241212","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2013.06.023","article-title":"Association between PAI-1 4G\/5G polymorphisms and osteonecrosis of femoral head: A meta-analysis","volume":"132","author":"Liang","year":"2013","journal-title":"Thromb Res"},{"key":"R27-13-20241212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1746-1596-8-169","article-title":"Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population","volume":"8","author":"Zhang","year":"2013","journal-title":"Diagn Pathol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_496_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:04:38Z","timestamp":1751497478000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/plasminogen-activator-inhibitor-1-promoter-sequence-variations-in-idiopathic-osteonecrosis-of-head-of-femur\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_496_19","relation":{},"ISSN":["0971-5916"],"issn-type":[{"type":"print","value":"0971-5916"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}